Albemarle Corp
NYSE:ALB

Watchlist Manager
Albemarle Corp Logo
Albemarle Corp
NYSE:ALB
Watchlist
Price: 58.645 USD 1.8%
Market Cap: 6.9B USD

Wall Street
Price Targets

ALB Price Targets Summary
Albemarle Corp

Wall Street analysts forecast ALB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALB is 83.982 USD with a low forecast of 58.58 USD and a high forecast of 162.75 USD.

Lowest
Price Target
58.58 USD
0% Downside
Average
Price Target
83.982 USD
43% Upside
Highest
Price Target
162.75 USD
178% Upside
Albemarle Corp Competitors:
Price Targets
688267
China Catalyst Holding Co Ltd
0% Upside
DSFIR
DSM-Firmenich AG
29% Upside
603659
Shanghai Putailai New Energy Technology Co Ltd
3% Upside
ADVENZYMES
Advanced Enzyme Technologies Ltd
27% Upside
FTK
Flotek Industries Inc
25% Downside

Revenue
Forecast

Revenue Estimate
Albemarle Corp

For the last 8 years the compound annual growth rate for Albemarle Corp's revenue is 9%. The projected CAGR for the next 3 years is 6%.

9%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Albemarle Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Albemarle Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALB's stock price target?
Price Target
83.982 USD

According to Wall Street analysts, the average 1-year price target for ALB is 83.982 USD with a low forecast of 58.58 USD and a high forecast of 162.75 USD.

What is Albemarle Corp's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Albemarle Corp's revenue is 9%. The projected CAGR for the next 3 years is 6%.

Back to Top